Login / Signup

An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis.

Hidehisa SaekiYukihiro OhyaNaoko BabaTomomi ImamuraDaisuke YokotaHidetsugu Tsubouchi
Published in: Dermatology and therapy (2024)
Clinical Trials. gov identifier: NCT05372653.
Keyphrases
  • clinical trial
  • open label
  • atopic dermatitis
  • phase ii
  • phase iii
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy